Cannabis Bioscience International Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dante Picazo
Chief executive officer
US$24.5k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 5.1yrs |
| CEO ownership | 37.9% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | -US$546k |
| May 31 2024 | US$25k | US$25k | -US$651k |
| Feb 29 2024 | n/a | n/a | -US$791k |
| Nov 30 2023 | n/a | n/a | -US$907k |
| Aug 31 2023 | n/a | n/a | -US$1m |
| May 31 2023 | US$25k | US$25k | -US$1m |
| Feb 28 2023 | n/a | n/a | -US$1m |
| Nov 30 2022 | n/a | n/a | -US$947k |
| Aug 31 2022 | n/a | n/a | -US$876k |
| May 31 2022 | US$23k | US$23k | -US$885k |
| Feb 28 2022 | n/a | n/a | -US$844k |
| May 31 2021 | US$5k | US$5k | -US$159k |
Compensation vs Market: Dante's total compensation ($USD24.50K) is below average for companies of similar size in the US market ($USD645.47K).
Compensation vs Earnings: Dante's compensation has been consistent with company performance over the past year.
CEO
Dante Picazo (68 yo)
5.1yrs
Tenure
US$24,500
Compensation
Mr. Dante Picazo is CEO & Director of Cannabis Bioscience International Holdings, Inc. (formerly known as China Infrastructure Construction Corp.) from December 19, 2019 and serves as its Chief Accounting...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Accounting Officer & Director | 5.1yrs | US$24.50k | 37.9% $ 2.4m | |
| National Medical Director | 5.1yrs | no data | 0.38% $ 24.0k | |
| Treasurer & Director | less than a year | no data | 10.46% $ 662.3k | |
| Member of Advisory Board | less than a year | no data | no data | |
| Director | less than a year | no data | no data |
0.9yrs
Average Tenure
62yo
Average Age
Experienced Board: CBIH's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 14:24 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cannabis Bioscience International Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|